We are absolutely thrilled to announce that Biobeat has been selected as a winner of the 2026 HMH Emerge Program!
Jointly run by Hackensack Meridian Health and Choose New Jersey, Inc., this incredible competition identifies and empowers innovative global health tech startups to establish and scale their operations in the U.S. market.
We are incredibly honored to be recognized for our work in delivering transformative solutions that address these significant cardiovascular health challenges, offering the market’s first FDA-cleared, cuffless 24-hour blood pressure monitoring solution (ABPM), completely reimagining how hypertension is diagnosed and managed.
A special thank you to Sandra Powell-Elliott, Albert Baker, Brett Sealove, Christopher Frangione, and Regina Cabrera, along with the entire HMH Emerge team, for this amazing opportunity and your support, and a huge congratulations to our fellow winners, Directed Systems Ltd and QuanBio.com!
Read more
here: https://lnkd.in/et8eA_s6
A big thank you to the Biobeat team involved in making this happen: Arik B., Jenny Baras, Jay Heimsoth, Sharon Dayan, and Ruthie Caspi-Molad!
